Literature DB >> 22987314

Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers.

Diethard Monbaliu1, Qiang Liu, Louis Libbrecht, Rita De Vos, Katrien Vekemans, Charlotte Debbaut, Olivier Detry, Tania Roskams, Jos van Pelt, Jacques Pirenne.   

Abstract

The wider use of livers from expanded criteria donors and donation after circulatory death donors may help to improve access to liver transplantation. A prerequisite for safely using these higher risk livers is the development of objective criteria for assessing their condition before transplantation. Compared to simple cold storage, hypothermic machine perfusion (HMP) provides a unique window for evaluating liver grafts between procurement and transplantation. In this proof-of-concept study, we tested basic parameters during HMP that may reflect the condition of human liver grafts, and we assessed their morphology after prolonged HMP. Seventeen discarded human livers were machine-perfused. Eleven livers were nontransplantable (major absolute contraindications and severe macrovesicular steatosis in the majority of the cases). Six livers were found in retrospect to be transplantable but could not be allocated and served as controls. Metabolic parameters (pH, lactate, partial pressure of oxygen, and partial pressure of carbon dioxide), enzyme release in the perfusate [aspartate aminotransferase (AST) and lactate dehydrogenase (LDH)], and arterial/portal resistances were monitored during HMP. Nontransplantable livers released more AST and LDH than transplantable livers. In contrast, arterial/portal vascular resistances and metabolic profiles did not differ between the 2 groups. Morphologically, transplantable livers remained well preserved after 24 hours of HMP. In conclusion, HMP preserves the morphology of human livers for prolonged periods. A biochemical analysis of the perfusate provides information reflecting the extent of the injury endured.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22987314     DOI: 10.1002/lt.23550

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  15 in total

1.  Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation.

Authors:  B G Bruinsma; H Yeh; S Ozer; P N Martins; A Farmer; W Wu; N Saeidi; S Op den Dries; T A Berendsen; R N Smith; J F Markmann; R J Porte; M L Yarmush; K Uygun; M-L Izamis
Journal:  Am J Transplant       Date:  2014-04-23       Impact factor: 8.086

2.  Graft Reconditioning before Liver Transplantation.

Authors:  Dieter P Hoyer; Thomas Minor
Journal:  Visc Med       Date:  2016-07-29

Review 3.  Machine perfusion of the liver: applications in transplantation and beyond.

Authors:  Carlo D L Ceresa; David Nasralla; Joerg-Matthias Pollok; Peter J Friend
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-01-07       Impact factor: 46.802

4.  Influence of perfusate on liver viability during hypothermic machine perfusion.

Authors:  Jun-Jun Jia; Jing Zhang; Jian-Hui Li; Xu-Dong Chen; Li Jiang; Yan-Fei Zhou; Ning He; Hai-Yang Xie; Lin Zhou; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

Review 5.  Hypothermic Oxygenated Liver Perfusion: Basic Mechanisms and Clinical Application.

Authors:  A Schlegel; P Kron; P Dutkowski
Journal:  Curr Transplant Rep       Date:  2015

6.  Evolution of dynamic, biochemical, and morphological parameters in hypothermic machine perfusion of human livers: A proof-of-concept study.

Authors:  H Abudhaise; B R Davidson; P DeMuylder; T V Luong; B Fuller
Journal:  PLoS One       Date:  2018-09-14       Impact factor: 3.240

Review 7.  Challenges and advances in optimizing liver allografts from donation after circulatory death donors.

Authors:  Andrew Ian Sutherland; Gabriel C Oniscu
Journal:  J Nat Sci Biol Med       Date:  2016 Jan-Jun

Review 8.  Machine Perfusion of Donor Livers for Transplantation: A Proposal for Standardized Nomenclature and Reporting Guidelines.

Authors:  S A Karangwa; P Dutkowski; P Fontes; P J Friend; J V Guarrera; J F Markmann; H Mergental; T Minor; C Quintini; M Selzner; K Uygun; C J Watson; R J Porte
Journal:  Am J Transplant       Date:  2016-06-13       Impact factor: 8.086

9.  Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD).

Authors:  Zoltan Czigany; Wenzel Schöning; Tom Florian Ulmer; Jan Bednarsch; Iakovos Amygdalos; Thorsten Cramer; Xavier Rogiers; Irinel Popescu; Florin Botea; Jiří Froněk; Daniela Kroy; Alexander Koch; Frank Tacke; Christian Trautwein; Rene H Tolba; Marc Hein; Ger H Koek; Cornelis H C Dejong; Ulf Peter Neumann; Georg Lurje
Journal:  BMJ Open       Date:  2017-10-10       Impact factor: 2.692

Review 10.  Pushing the Limits: Machine Preservation of the Liver as a Tool to Recondition High-Risk Grafts.

Authors:  Yuri L Boteon; Simon C Afford; Hynek Mergental
Journal:  Curr Transplant Rep       Date:  2018-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.